News
About Vepdegestrant Vepdegestrant is an investigational, orally bioavailable PROteolysis TArgeting Chimera (PROTAC) estrogen receptor degrader. Vepdegestrant is being developed as a potential ...
Submitted New Drug Application for vepdegestrant for the treatment of ESR1m, ER+/HER2- advanced or metastatic breast cancer – ...
Q2 2025 Earnings Call Transcript August 6, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.83836, ...
With the completion of the successful Phase 3 VERITAC-2 trial, in June 2025 Pfizer and Arvinas filed an NDA seeking FDA approval.
This page contains the walkthrough for the Deep Stone Crypt raid in Destiny 2: Beyond Light, as well as tips that will help you ...
This page of IGN's Mass Effect 2 wiki guide covers the upgrades needed for everyone to survive in the Suicide Mission finale, including what you need to ...
The Global Selective Estrogen Receptor Degrader (SERD) Market is rapidly evolving, highlighted by key innovations like FDA-approved Orserdu and the upcoming vepdegestrant, a pioneering PROTAC ...
The Global Selective Estrogen Receptor Degrader (SERD) Market is rapidly evolving, highlighted by key innovations like FDA-approved Orserdu and the upcoming vepdegestrant, a pioneering PROTAC-based ...
While the city builder sequel has a lot of new toys to play with, we have the best Cities Skylines 2 mods to perfect your experience.
Now Path of Exile 2 is in early access, if you're wondering when the game enters full release, here's everything we know about what to expect.
The best 2% cash-back credit cards lavish you with valuable rewards and benefits, often with no annual fee. Determine which works best for you with Forbes Advisor’s expert analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results